The Patent Protection of Flurbiprofen: Understanding the Timeline
Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, inflammation, and fever. It is available in various forms, including oral tablets, capsules, and topical creams. As with any pharmaceutical product, the patent protection of flurbiprofen is a crucial aspect to consider. In this article, we will delve into the patent protection timeline of flurbiprofen and explore the factors that influence its duration.
What is Patent Protection?
Before we dive into the specifics of flurbiprofen's patent protection, let's briefly discuss what patent protection is. Patent protection is a legal right granted to the inventor of a new and innovative product, process, or method. In the case of pharmaceuticals, patent protection is granted to the manufacturer of a new drug, allowing them to exclusively market and sell the product for a certain period.
The Patent Life Cycle of Flurbiprofen
Flurbiprofen was first approved by the US FDA in 1974. The patent life cycle of flurbiprofen can be broken down into several stages:
* Patent Filing Date: The patent filing date is the date when the patent application is submitted to the patent office. For flurbiprofen, the patent filing date is not publicly available.
* Patent Grant Date: The patent grant date is the date when the patent is officially granted. For flurbiprofen, the patent grant date is also not publicly available.
* Patent Expiration Date: The patent expiration date is the date when the patent protection expires. According to DrugPatentWatch.com, the patent expiration date for flurbiprofen is December 15, 2024.
Factors Influencing Patent Protection Duration
Several factors can influence the duration of patent protection for a pharmaceutical product like flurbiprofen:
* Patent Term Extension: Patent term extension is a provision that allows the patent holder to extend the patent term by up to five years. This is typically granted when the patent holder can demonstrate that the regulatory approval process took longer than usual.
* Patent Term Adjustment: Patent term adjustment is a provision that allows the patent holder to adjust the patent term to account for delays in the regulatory approval process.
* Generic Entry: Generic entry occurs when a generic version of the product is approved by the regulatory authority. This can lead to a loss of market share for the original product.
Impact of Patent Expiration on Flurbiprofen
The expiration of flurbiprofen's patent protection will have significant implications for the pharmaceutical industry:
* Generic Entry: With the patent protection expiring, generic versions of flurbiprofen will become available, leading to increased competition and potentially lower prices.
* Market Share: The original product's market share will likely decline as generic versions become more widely available.
* Research and Development: The expiration of patent protection may lead to a decrease in research and development efforts for new products, as the original product's market share is reduced.
Expert Insights
According to a report by the Pharmaceutical Research and Manufacturers of America (PhRMA), the expiration of patent protection can have a significant impact on the pharmaceutical industry:
"The expiration of patent protection can lead to a loss of market share for the original product, as well as a decrease in research and development efforts for new products." - PhRMA Report
Conclusion
In conclusion, the patent protection of flurbiprofen will expire on December 15, 2024. The expiration of patent protection will have significant implications for the pharmaceutical industry, including generic entry, market share, and research and development efforts. As the industry continues to evolve, it is essential to stay informed about the patent protection timeline of pharmaceutical products like flurbiprofen.
Key Takeaways
* The patent protection of flurbiprofen will expire on December 15, 2024.
* The expiration of patent protection will lead to generic entry, market share decline, and decreased research and development efforts.
* The pharmaceutical industry must adapt to the changing landscape of patent protection.
Frequently Asked Questions
1. Q: What is the patent protection timeline for flurbiprofen?
A: The patent protection timeline for flurbiprofen includes the patent filing date, patent grant date, and patent expiration date.
2. Q: What is the patent expiration date for flurbiprofen?
A: According to DrugPatentWatch.com, the patent expiration date for flurbiprofen is December 15, 2024.
3. Q: What are the implications of patent expiration for flurbiprofen?
A: The expiration of patent protection will lead to generic entry, market share decline, and decreased research and development efforts.
4. Q: What is patent term extension?
A: Patent term extension is a provision that allows the patent holder to extend the patent term by up to five years.
5. Q: What is patent term adjustment?
A: Patent term adjustment is a provision that allows the patent holder to adjust the patent term to account for delays in the regulatory approval process.
Sources
1. DrugPatentWatch.com. (n.d.). Flurbiprofen Patent Expiration Date. Retrieved from <https://www.drugpatentwatch.com/patent/US-4103906>
2. Pharmaceutical Research and Manufacturers of America (PhRMA). (n.d.). The Impact of Patent Expiration on the Pharmaceutical Industry. Retrieved from <https://www.phrma.org/-/media/Files/PhRMA/PhRMA-Website/Research-and-Development/The-Impact-of-Patent-Expiration-on-the-Pharmaceutical-Industry.pdf>
3. US FDA. (n.d.). Flurbiprofen. Retrieved from <https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm>